Beruflich Dokumente
Kultur Dokumente
Classification of Seizures
Partial: simple or complex Generalized: absence, tonic, clonic, tonic-clonic, myoclonic, febrile
Pathophysiology of Seizures
The Interictal Spike (paroxysmal depolarization shift) Increased excitability
Membrane depolarization, potassium buildup Increased excitatory (EAA, glutamate) input Decreased inhibitory (GABA) input
Decreased GABA Decreased binding of GABA and benzodiazepines Decreased Cl- currents in response to GABA Decreased glutamate decarboxylase activity (synthesizes GABA) Interfere with GABA causes seizures
Strategies in Treatment
Stabilize membrane and prevent depolarization by action on ion channels
Increase GABAergic transmission Decrease EAA transmission
Classification of Anticonvulsants
Action on Ion Channels
Na+: Phenytoin, Carbamazepine, Lamotrigine Topiramate Valproic acid Ca++: Ethosuximide Valproic acid
Na+: For general tonic-clonic and partial seizures Ca++: For Absence seizures
Most effective in myoclonic but also in tonic-clonic and partial Clonazepam: for Absence
Classification of Anticonvulsants
Classical
Phenytoin Phenobarbital Primidone Carbamazepine Ethosuximide Valproic Acid Trimethadione
Newer
Lamotrigine Felbamate Topiramate Gabapentin Tiagabine Vigabatrin Oxycarbazepine Levetiracetam Fosphenytoin Others
R1 R2
R3
Phenytoin
Ethosuximide
Trimethadione
Phenobarbital
Carbamazepine
Valproic Acid
Phenytoin or Diphenylhydantoin
Limited water solubility not given i.m. Slow, incomplete and variable absorption. Extensive binding to plasma protein. Metabolized by hepatic ER by hydroxylation. Chance for drug interactions. Therapeutic plasma concentration: 10-20 g/ml Shift from first to zero order elimination within therapeutic concentration range.
Dose (mg/day)
Phenytoin Toxicity
Chronic Toxicity Dose related vestibular/cerebellar effects Behavioral changes Gingival Hyperplasia GI Disturbances Sexual-Endocrine Effects:
Osteomalacia Hirsutism Hyperglycemia
Chronic Toxicity Folate Deficiency - megaloblastic anemia Hypoprothrombinemia and hemorrhage in newborns Hypersenstivity Reactions could be severe. SLE, fatal hepatic necrosis, Stevens-Johnson syndrome. Pseudolymphoma syndrome Teratogenic Drug Interactions: decrease (cimetidine, isoniazid) or increase (phenobarbital, other AEDs) rate of metabolism; competition for protein binding sites.
Fosphenytoin
A Prodrug. Given i.v. or i.m. and rapidly converted to phenytoin in the body. Avoids local complications associated with phenytoin: vein irritation, tissue damage, pain and burning at site, muscle necrosis with i.m. injection, need for large fluid volumes. Otherwise similar toxicities to phenytoin.
Cl-
GABA
Vigabatrin
Tiagabine
Gabapentin
GABA-T
VGB
BZD
TGB
GABA-T
VGB
Valproic Acid
Effective in multiple seizure types. Blocks Na and Ca channels. Inhibits GABA transaminase. Increases GABA synthesis. Toxicity: most serious: fulminant hepatitis. More common if antiepileptic polytherapy in children < 2 years old. (?) Toxic metabolites involved. Drug interactions: inhibits phenobarbital and phenytoin metabolism.
Other Drugs
Topiramate; multiple mechanisms of action (Na channel, GABA enhancement like BZD, antagonist at AMPA subtype of glutamate receptors (not NMDA). Felbamate: multiple mechanisms: Na channel block; modulates glutamate transmission interacts with glycine site. Serious hematological and hepatic toxicities.
Treatment of Epilepsy
Start with a single agent. Raise to maximum tolerated dose before shifting to another. If therapy fails may use combination of drugs. Frequent physician visits early on and therapeutic drug monitoring. Importance of compliance. Aim and duration of therapy.